1. Home
  2. BVS

BVS

Bioventus Inc.

Logo Bioventus Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Founded: 2011 Country:
United States
United States
Employees: N/A City: DURHAM
Market Cap: 366.5M IPO Year: 2021
Target Price: $8.00 AVG Volume (30 days): 142.7K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.49 EPS Growth: N/A
52 Week Low/High: $0.86 - $6.08 Next Earning Date: 05-09-2024
Revenue: $512,345,000 Revenue Growth: 0.04%
Revenue Growth (this year): 4.09% Revenue Growth (next year): 6.43%

Share on Social Networks: